Real-World, Single-Center Analysis of Cutaneous Adverse Events with Nemolizumab: Toward Safer and More Effective Use.

Sugiyama A, Nakahara T, Kojima K, Nishie H, Nishimura M, Hiramoto T.

Open source

DOI
10.3390/jcm14248657
Published
2025-12-06
Container
J Clin Med
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/jcm14248657,
  title = {Real-World, Single-Center Analysis of Cutaneous Adverse Events with Nemolizumab: Toward Safer and More Effective Use.},
  author = {Sugiyama A and  Nakahara T and  Kojima K and  Nishie H and  Nishimura M and  Hiramoto T.},
  year = {2025},
  journal = {J Clin Med},
  doi = {10.3390/jcm14248657},
  url = {https://doi.org/10.3390/jcm14248657}
}

RIS

TY  - JOUR
TI  - Real-World, Single-Center Analysis of Cutaneous Adverse Events with Nemolizumab: Toward Safer and More Effective Use.
AU  - Sugiyama A
AU  -  Nakahara T
AU  -  Kojima K
AU  -  Nishie H
AU  -  Nishimura M
AU  -  Hiramoto T.
PY  - 2025
JO  - J Clin Med
DO  - 10.3390/jcm14248657
UR  - https://doi.org/10.3390/jcm14248657
ER  -

APA

A, S., T, N., K, K., H, N., M, N., & T., H. (2025). Real-World, Single-Center Analysis of Cutaneous Adverse Events with Nemolizumab: Toward Safer and More Effective Use.. J Clin Med. https://doi.org/10.3390/jcm14248657

Source records